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A B S T R A C T
Disseminated Mycobacterium avium complex (MAC) infection is an important AIDS-deﬁning
opportunistic infection. The introduction of antimicrobial prophylaxis and antiretroviral therapy
(ART) markedly reduced the incidence of disseminated MAC infection and improved the survival of
affected individuals. However, it seems that patients with new or recurrent MAC infection are still
encountered in clinical practice. Our images captured the characteristic endoscopic ﬁndings of MAC
duodenitis. The gastrointestinal (GI) tract appears to be a common port of entry for MAC infection in
patients with AIDS. Early recognition of GI MAC infection by endoscopy in HIV-infected patients and
initiation of anti-MAC therapy and ART may reduce morbidity and mortality.
 2014 he Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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jo u rn al ho m epag e: ww w.els evier . c om / lo cat e/ idc rA 39-year-old man presented with 3-month history of cough
and 1-month history of fever, diarrhea and shortness of breath.
Neither social nor medical history was remarkable except past
sexual intercourses with multiple male partners.
On clinical examination, he had no rales and abnormal ﬁndings
in the abdomen. Laboratory examinations showed HIV-1-positive
with CD4 count 12 cells/mm3. Chest X-ray on admission showed
bilateral reticulonodular shadows and a cavity on the right upper
lobe (Fig. 1). Sputum culture was positive for Mycobacterium avium
complex (MAC) and Mycobacterium kansasii (M. kansasii). Upper
gastrointestinal endoscopy reveled diffusely scattered whitish-
yellowish nodules measuring 5–10 mm in size in the duodenum
(Fig. 2), and MAC was also cultured from the biopsy specimens.
After 6-month of anti-mycobacterial therapy (isoniazid, rifam-
picin, ethambutol and clarithromycin), the symptoms had been
resolved, and the improvement of the lung and duodenum lesions
was noted.
Among HIV-infected individuals, disseminated MAC is usually
seen in patients with a CD4 count of less than 50 cells/mm3 [1,2].
The risk of MAC bacteremia is approximately 60% within in 1 year
for patients with MAC colonization in the gastrointestinal (GI) tract
as compared with those without GI involvement [3]. The
introduction of effective antiretroviral therapy (ART) for HIV
infection and antimicrobial prophylaxis against MAC infection
have had a major impact on the incidence and the clinical course of
MAC infection in patients with AIDS, but patients with new or* Corresponding author. Tel.: +81 3 3202 7181.
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2214-2509/ 2014 he Authors. Published by Elsevier Ltd. This is an open access article unrecurrent MAC infection are still encountered in clinical practice.
Because GI MAC infection may be the ﬁrst presentation of AIDS
associated opportunistic infection, it is essential to be alert for
endoscopic ﬁndings, even in the era of effective ART. Early
recognition of GI MAC infection by endoscopy in HIV-infected
patients and initiation of anti-MAC therapy and ART may reduce
morbidity and mortality.Fig. 1. Chest radiograph in 39-year-old HIV-infected patient showing bilateral
reticulonodular shadows and a cavity on the right upper lobe.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Fig. 2. Upper gastrointestinal endoscopy reveled diffusely scattered whitish-
yellowish nodules measuring 5–10 mm in size in the duodenum.
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